Get the Weekly Intelligence Brief — top committee picks every Sunday.
NASDAQ · STOCK

Repligen

RGEN Healthcare Unknown Updated July 21, 2026
$137.15
52W $100.99 – $175.77
57/100
159.9
1.06
Explore RGEN Further
📈 Rating History 💰 Earnings 📰 Recent Events 🔄 What Changed 📖 Thesis Evolution 🔍 Similar Stocks
AI Committee Verdict
Watch
Conviction: Contested · 57% agreement · 7 analysts
+2.0%
-0.8%
2.44:1
Contested
Is RGEN Bullish or Bearish?
Mixed. Innellis AI committee rates Repligen (RGEN) Watch with a composite score of 57/100 , based on 7 analysts with 57% agreement. Last updated July 21, 2026.
Executive Summary
The committee is genuinely divided. Macro Analyst sees a compelling case — market regime is bullish (bull market -- normal position sizing). Value Analyst remains cautious — p/e of 161.6 is expensive by classic value standards. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
  • Daily volatility (ATR%) above ~3% is treated as elevated risk.
Bear Case
  • MACD histogram is negative (-0.058) — bearish momentum.
  • Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
Price History (6M)
AI Investment Committee
Committee Consensus As of July 21, 2026
Overall Committee Score
57/100
Agreement
57%
Analysts
7
Conviction
Contested
Value Analyst bearish
38 / 100 · High confidence
Multiples don't clear a genuine value bar here, or cheapness looks justified by weak fundamentals
− P/E of 161.6 is expensive by classic value standards
Growth Analyst bullish
60 / 100 · High confidence
Strong, accelerating growth with consistent execution
+ 3 consecutive earnings beats -- consistent execution
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst bullish
61 / 100 · High confidence
Price action is constructive -- trend and momentum agree
+ MACD histogram positive -- bullish momentum
Risk Analyst neutral
58 / 100 · Moderate confidence
Moderate risk -- no single red flag, but nothing that clearly de-risks the position either
+ Low leverage (debt-to-equity 0.26) -- balance sheet can absorb a shock
− Bollinger bandwidth of 18.9% signals elevated volatility
Macro Analyst bullish
70 / 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst bullish
70 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.38 across 8 articles, 14d)
Portfolio Manager neutral
45 / 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2975.52)
Open Full Terminal →
Investment Thesis Evolution

Committee score moved marginally from 57.3 to 57.3.

Comparing 2026-07-20 to 2026-07-21 (1 day apart).

Technical Analysis
RSI (14)
57.7
Neutral
MACD Histogram
-0.059
Bearish Momentum
Trend Direction
Sideways
Weekly: Sideways
Market Structure
Mixed
Support
$144.32
Resistance
$148.38
Bollinger %B
0.66
Inside Bands
Price vs Moving Averages
EMA 9
$145.22 Below
EMA 21
$140.92 Below
EMA 50
$133.89 Above
EMA 200
$134.01 Above
Fundamental Analysis
Valuation
54
Growth
59
Profitability
0
Financial Health
100
Cash Flow
37
Valuation
P/E Ratio 159.9×
P/B Ratio 3.89×
PEG Ratio 0.05
Dividend Yield 0.00%
52W High $175.77
52W Low $100.99
Quality & Growth
ROE 2.3%
ROA 1.7%
Gross Margin 50.2%
Operating Margin 8.8%
Revenue Growth YoY
Debt / Equity 0.33
AI Fundamental Assessment
P/E ratio of 159.9 (rich relative to a 15-40x range); Price-to-book of 3.9x; PEG ratio of 0.1 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 0.0%; Return on assets of 0.0%; Net margin of 0.1%; Gross margin of 0.5%; Current ratio of 9.20 (healthy short-term liquidity); Debt-to-equity of 0.33; Free cash flow margin of 0.8% (thin cash generation); Free cash flow per share is positive (1.85); Most recent quarter beat estimates by 21.9%; 3 consecutive earnings beats; EPS growth decelerating (+6.5% -> -2.0% QoQ); Analyst estimates falling over recent quarters
Key Risks
  • MACD histogram is negative (-0.058) — bearish momentum.
  • Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
This risk summary is generated from quantitative data signals, not qualitative opinion. All investors should conduct their own due diligence. This is not financial advice.
Get the Full RGEN Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal → Mobile
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime